The FDA has approved SimpleScreen CRC, a blood-based colorectal cancer screening test developed by Brisbane, Calif.-based Freenome, on July 27, according to a July 27 news release. This is the second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results